| |
| |
|
| Insider
Information: |
Maddon Paul J |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
909,891 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$3,730,553 |
|
|
|
Indirect Value
|
$4,100 |
|
|
| Total
Shares |
910,891 |
|
|
| Total
Value |
$3,734,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2010-12-01 |
909,891 |
2005-04-01 |
1,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-07-17 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-07-17 |
4 |
AS |
$21.10 |
$253,224 |
D/D |
(12,000) |
640,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-08-01 |
4 |
AS |
$21.54 |
$258,900 |
D/D |
(12,000) |
640,828 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-08-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
647,828 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-08-15 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-08-15 |
4 |
AS |
$20.20 |
$242,412 |
D/D |
(12,000) |
640,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-09-01 |
4 |
AS |
$22.72 |
$272,640 |
D/D |
(12,000) |
640,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-09-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,828 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-09-15 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
645,828 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-09-15 |
4 |
AS |
$23.66 |
$287,350 |
D/D |
(12,000) |
640,828 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-10-02 |
4 |
AS |
$23.37 |
$280,476 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-10-16 |
4 |
AS |
$24.00 |
$288,000 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-10-16 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-11-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-11-01 |
4 |
AS |
$25.96 |
$311,568 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-11-15 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
645,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-11-15 |
4 |
AS |
$29.07 |
$349,752 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-12-01 |
4 |
AS |
$26.75 |
$321,843 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-12-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
645,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-12-15 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
652,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2006-12-15 |
4 |
AS |
$26.14 |
$313,668 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-01-03 |
4 |
AS |
$25.68 |
$308,124 |
D/D |
(12,000) |
640,987 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-01-16 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
653,160 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-01-16 |
4 |
AS |
$28.58 |
$342,912 |
D/D |
(12,000) |
641,160 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
• – • |
2007-02-01 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
653,160 |
0 |
- |
|
123 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
